Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

154 results

Stibbe advises Avista Capital Partners

Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.

Accountants advising in real estate transactions: be aware of penalties in mortgage deeds

The Court of Appeal of Arnhem-Leeuwarden ruled on 3 March 2020 that an accountant did not properly advise her client with respect to a sale of real estate (ECLI:NL:GHARL:2020:1875).

Auditor liable for not including a provision for a third party claim?

In a recent case, the Court of Appeal of Arnhem-Leeuwarden dismissed a claim of the bankruptcy trustee of Welsec against an audit firm for failing to ensure that the audited company, Welsec, included a provision in its annual accounts for [...]

Klimaatbeleid nog onvoldoende in de dagelijkse praktijk van accountants

Uit onderzoek van de Nederlandse Beroepsorganisatie van Accountants (NBA) samen met de Rijksuniversiteit Groningen (RuG) blijkt dat externe accountants zich nog onvoldoende bezighouden met klimaatvraagstukken.

Contracts & Corona: force majeure and related topics

The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions.

Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review

Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. 

 

Stibbe advises Aedifica

Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Dordrecht and the acquisitions and leases of recently completed healthcare residences in Harderwijk and Berkel-Enschot (NL).

Stibbe advises LDA Capital

Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.

Stibbe advises Agendia

Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.

Stibbe advises Canon Medical Systems

Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.

Stibbe advises Aedifica

Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).

Stibbe advises Aedifica

Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. 

Stibbe advises on the equity offering of ProQR

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

Stibbe advises SleepScore Labs

Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.

Stibbe advises Lundbeck

Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.

Verslaggeving over ‘in-control’ door Nederlandse beursvennootschappen

Consistentie in de ‘in-control verklaringen’ van Nederlandse beursvennootschappen is ver te zoeken. Dit blijkt uit onderzoek dat Steven Hijink deed samen Jos de Groot (PwC) voor het Maandblad voor Accountancy en Bedrijfseconomie. Deze ‘in-control verklari

Stibbe, KPMG and NVB Sustainable Finance Week

The Sustainable Finance Week - organised by Stibbe, KPMG and NVB - will take place across 4 afternoons, starting on Monday 31 May 2021. Through an online conference platform, we will present a variety of live information sessions on the EU Sustainable Fin

Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe

Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.

Pagination

  • Previous page
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Next page
Reset filters
Date
Content type
  • Article (55)
  • Event (5)
  • Inside Stibbe (3)
  • Matter (52)
  • Podcast (3)
  • People (36)
Expertise
  • (-) Audit Firms and Accountancy (76)
  • (-) Healthcare and Life Sciences (85)
  • Banking and Finance (428)
  • Capital Markets (247)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (862)
  • Corporate Investigations (31)
  • Criminal Law and Enforcement (142)
  • Digital Economy (108)
  • Employment, Benefits and Pensions (409)
  • Energy, Industry and Climate (311)
  • Environment and Planning (878)
  • ESG & Sustainability (295)
  • EU and Competition Law (492)
  • Financial Regulation (172)
  • Infrastructure and Mobility (192)
  • Insurance (36)
  • Intellectual Property (120)
  • Investment Funds (141)
  • Litigation and Arbitration (426)
  • Privacy and Data Protection (202)
  • Private Equity (197)
  • Procurement Law (122)
  • Public Law (1187)
  • Real Estate (469)
  • Restructuring and Insolvency (116)
  • Sports (25)
  • Stibbe StartsUP (29)
  • Tax (444)
  • Technology, Media and Telecommunications (330)
  • Unfair Competition and Consumer Protection (186)
Jurisdiction
  • BE Law (23)
  • EU Law (21)
  • LU Law (7)
  • NL Law (92)
Language
  • Dutch (36)
  • English (116)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information